212 related articles for article (PubMed ID: 9636573)
41. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
[TBL] [Abstract][Full Text] [Related]
42. Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial.
Yang HC; Holman MJ; Langhoff E; Ulsh PJ; Dellock CA; Gupta M; Ahsan N
Transplant Proc; 1999; 31(1-2):1121-4. PubMed ID: 10083501
[No Abstract] [Full Text] [Related]
43. Generic immunosuppressants in hematopoietic cell transplantation.
Cutler C; Kesselheim A; Gabardi S; Andersson BS; Carpenter P; Khoury HJ; Litzow M; Rowley SD; Lanum S; Leather H; Tina Shih YC; Gale RP; Wingard JR; Appelbaum FR; Anasetti C;
Biol Blood Marrow Transplant; 2011 Mar; 17(3):285-90. PubMed ID: 21087678
[No Abstract] [Full Text] [Related]
44. Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity.
Torras J; Figueras J; Lama C; Fabregat J; Ramos E; Rafecas A; Gil-Vernet S; Pares D; Busquets J; Jaurrieta E
Transplant Proc; 1999 Sep; 31(6):2430. PubMed ID: 10500656
[No Abstract] [Full Text] [Related]
45. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
[No Abstract] [Full Text] [Related]
46. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
[TBL] [Abstract][Full Text] [Related]
47. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
[TBL] [Abstract][Full Text] [Related]
48. Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation.
Wang XH; Tang XD; Xu D
Transplant Proc; 2000 Nov; 32(7):1702-3. PubMed ID: 11119899
[No Abstract] [Full Text] [Related]
49. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
[TBL] [Abstract][Full Text] [Related]
50. Neuromuscular complication after liver transplant in children: a single-center experience.
Dehghani SM; Honar N; Inaloo S; Gholami S; Kazemi K; Bahador A; Haghighat M; Malek-Hosseini SA
Exp Clin Transplant; 2010 Mar; 8(1):9-13. PubMed ID: 20199365
[TBL] [Abstract][Full Text] [Related]
51. Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
Grasser B; Iberer F; Schaffellner S; Kniepeiss D; Stauber R; Koshsorur G; Rehak P; Tscheliessnigg KH
Transplant Proc; 2001 May; 33(3):2154-6. PubMed ID: 11377484
[No Abstract] [Full Text] [Related]
52. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
53. Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation.
Cai TH; Esterl RM; Nichols L; Cigarroa F; Speeg KV; Halff GA
Transplant Proc; 1998 Jun; 30(4):1413-4. PubMed ID: 9636572
[No Abstract] [Full Text] [Related]
54. Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantation.
Pfitzmann R; Klupp J; Langrehr JM; Neuhaus R; Junge G; Settmacher U; Steinmüller T; Neuhaus P
Transplant Proc; 2002 Nov; 34(7):2938-9. PubMed ID: 12431665
[No Abstract] [Full Text] [Related]
55. Evaluation of inosin-5'-monophosphate dehydrogenase activity during maintenance therapy with tacrolimus.
Maiguma T; Yosida T; Otsubo K; Okabe Y; Sugitani A; Tanaka M; Oishi R; Teshima D
J Clin Pharm Ther; 2010 Feb; 35(1):79-85. PubMed ID: 20175815
[TBL] [Abstract][Full Text] [Related]
56. Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study.
Squifflet JP; Vanrenterghem Y; van Hooff JP; Salmela K; Rigotti P;
Transplant Proc; 2002 Aug; 34(5):1584-6. PubMed ID: 12176495
[No Abstract] [Full Text] [Related]
57. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
Yu L; Wang Y; Fu SJ; Cheng XJ
Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
[No Abstract] [Full Text] [Related]
58. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
[TBL] [Abstract][Full Text] [Related]
59. Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
Miki T; Goller A; Rao A; Wang X; Yin WY; Tandin A; Fung JJ; Starzl TE; Valdivia LA
Transplant Proc; 1998 Jun; 30(4):1091-2. PubMed ID: 9636444
[No Abstract] [Full Text] [Related]
60. Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
Saliba F; Rostaing L; Gugenheim J; Durand F; Radenne S; Leroy V; Neau-Cransac M; Calmus Y; Salamé E; Pageaux GP; Duvoux C; Taguieva N; Sinnasse-Raymond G; Sebagh M; Samuel D; Marquet P
Transplantation; 2016 Aug; 100(8):1705-13. PubMed ID: 27454919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
